Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessShockwave Medical to be Acquired for $13.1 Billion by Johnson & Johnson

Shockwave Medical to be Acquired for $13.1 Billion by Johnson & Johnson

Add to Favorite
Added to Favorite


Johnson & Johnson (NYSE:JNJ) has confirmed its acquisition of Shockwave Medical (NASDAQ:SWAV) for a $13.1 billion. For every Shockwave share, Johnson & Johnson will pay $335. The agreement received unanimous approval from the boards of both firms.
According to a press statement from the company, this acquisition is expected to enhance the operating margins of Johnson & Johnson and its MedTech division immediately. Nonetheless, financing expenses will marginally decrease the adjusted earnings per share by approximately $0.10 in 2024 and $0.17 in 2025.
The acquisition of Shockwave, with its pioneering Intravascular Lithotripsy (IVL) technology, offers a unique opportunity to expand Johnson & Johnson’s influence in cardiovascular interventions and deliver increased value to patients, shareholders, and healthcare systems worldwide. Shockwave specializes in developing a device that utilizes shockwaves to break apart calcified plaque in the arteries of the heart, a method akin to the treatment of kidney stones.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Melius Initiates Coverage on Uber with Hold Rating, Highlights Cross-Selling Strategy

Melius analysts initiated coverage on Uber (NYSE:UBER) with a...

Rosenblatt Boosts Texas Instruments Price Target to $250 Ahead of Q2 Results

Rosenblatt analysts increased their price target for Texas Instruments...

Western Alliance’s Q2 Earnings Review By RBC Capital

RBC Capital analysts raised their price target for Western...